Article Name Clinical & Diagnostic
The RAD Temp ensures uninterrupted cancer treatment in Northeast Texas as TRMC upgrades its vault and linear accelerator for more precise, advanced care.
01st September, 2025
This designation will help streamline the reimbursement process for providers and further validate the clinical utility of these advanced wound care solutions
29th August, 2025
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine.
13th August, 2025
The company’s second US LDT adds automated qFibrosis® analysis with stain-free SHG imaging, providing continuous, reproducible scores that cut inter-reader variability and support earlier, more personalised care.
12th August, 2025
Regulatory green light marks full commercial launch of LungVision, enhancing early lung cancer detection through AI-driven 3D imaging for more precise bronchoscopic diagnostics.
06th August, 2025
Dr Ashton Harper, Global Medical Affairs Lead for Neurosciences at Roche Diagnostics, discusses how the CE-marked blood test enhances early detection, reduces invasive diagnostics, and aligns with the advent of disease-modifying therapies.
06th August, 2025
Sandeep Brar, Vice President of Clinical and Regulatory at Medtronic, shares insights on the scientific rationale, catheter design, and the future of multi-organ denervation in managing hypertension.
04th August, 2025
Initiative aims to reduce anxiety and improve patient understanding after lung nodule detection, offering clear resources and guidance to support informed decisions and early intervention.
04th August, 2025
New AI models bring precision and speed to neuro-oncology, enabling fully automated volumetric analysis and seamless integration into radiology, surgery, and radiation oncology workflows—advancing diagnostic confidence and patient care.
31st July, 2025
Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types
30th July, 2025
Strategic alliance enhances in-home screening with advanced molecular diagnostics, AI-driven insights, and flexible testing options to improve outcomes for patients and underserved communities.
29th July, 2025
New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness.
29th July, 2025
Designed for seamless remote use, the ‘Anywhere powered by Linus Health™’ platform brings early detection of cognitive decline to payers, pharma, wellness providers, and consumers—anytime, anywhere.
29th July, 2025
Vinmec Central Park pioneers breakthrough treatment using AutoGuide™ system, offering new hope for children with drug-resistant epilepsy and marking a significant leap towards global neurological care standards.
29th July, 2025
New minimally invasive diagnostic aids in ruling out Alzheimer’s disease early, expanding access to timely and accurate neurological assessments across Europe.
24th July, 2025
Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment
24th July, 2025
How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development.
23rd July, 2025
Renowned oncology expert joins to support advancement of next-generation cancer diagnostics and therapeutics.
21st July, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer